Unified Patent Court (UPC) analytics are now available. Check here

EP3391890

MERCK SHARP & DOHME
Application Number
EP18171672A
Filing Date
Jun 24, 2011
Status
Granted And Under Opposition
Jul 23, 2021
Grant Date
Aug 25, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3391890B1 was granted on Aug 25, 2021 by Merck Sharp & Dohme The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ETHYPHARMMay 25, 2022ADMISSIBLE
FRESENIUS KABI DEUTSCHLANDMay 25, 2022ADMISSIBLE
GENERICS UKMay 25, 2022ADMISSIBLE
AERAMay 25, 2022WITHDRAWN

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS5134127
N/A
OppositionUS2009270348
N/A
OppositionWO2005117831
N/A
OppositionWO2007047253
N/A
OppositionUS5661151
N/A
OppositionUS2008097372
N/A
OppositionWO2009018069
N/A
OppositionWO9858677
N/A
OppositionWO2012005973
N/A
OppositionEP2588116
N/A
OppositionUS5257985
N/A
OppositionWO03092574
N/A
OppositionWO2009134347
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.